Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

Direct Payment

$120,000.00

Identification of host factors that restrict replication of the causative agent of Legionnaires' disease

EF 2025-26

Résumé
Legionnaires' disease is a severe form of pneumonia caused by the bacterium Legionella pneumophila and related species. This bacterium thrives in warm-water systems such as hot tubs, fountains, and cooling towers where it can spread into the air and be inhaled. Older adults and people with underlying health conditions are at greatest risk, and the disease is fatal in about one in ten cases. A recent outbreak in London, Ontario highlights the urgency of addressing this growing public health threat. Normally, immune cells in the lungs, called macrophages, engulf and destroy invading bacteria. However, Legionella can survive by creating a protective compartment inside these cells, known as the Legionella-containing vacuole (LCV). Sometimes macrophages detect that this compartment is abnormal and rupture it, which triggers a form of self-destruction called pyroptosis, which kills both the cell and the bacteria inside. Otherwise, the bacteria spread further. This is a critical step in progression of Legionnaire's disease, but the process behind it is poorly understood. My research will investigate the cellular pathways that allow macrophages to rupture the LCV and fight infection. I will grow macrophages derived from genetically diverse mice, expose them to Legionella, and identify genetic factors that control LCV rupture and cellular death. Using genetic analysis and advanced microscopy, I will characterize the mechanisms behind this process. By uncovering how immune cells recognize and eliminate Legionella, this project will guide the development of new therapies to treat or prevent Legionnaires' disease. Notably, restriction of other pathogens, such as Chlamydia trachomatis, occurs in a similar fashion, so this work is likely to provide insights on additional infectious diseases. Ultimately, these discoveries could improve patient outcomes, reduce the burden of pneumonia and related infections, and strengthen our ability to protect public health.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
553018
Name
Callon Lily S
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Identification of host factors that restrict replication of the causative agent of Legionnaires' disease
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Cell-Autonomous Immunity; Crispra; Crispri; Genetics; Immunology; Intracellular Infection; Macrophage; Pyroptosis; Quantitative Trait Loci Mapping
Abstract
Legionnaires' disease is a severe form of pneumonia caused by the bacterium Legionella pneumophila and related species. This bacterium thrives in warm-water systems such as hot tubs, fountains, and cooling towers where it can spread into the air and be inhaled. Older adults and people with underlying health conditions are at greatest risk, and the disease is fatal in about one in ten cases. A recent outbreak in London, Ontario highlights the urgency of addressing this growing public health threat. Normally, immune cells in the lungs, called macrophages, engulf and destroy invading bacteria. However, Legionella can survive by creating a protective compartment inside these cells, known as the Legionella-containing vacuole (LCV). Sometimes macrophages detect that this compartment is abnormal and rupture it, which triggers a form of self-destruction called pyroptosis, which kills both the cell and the bacteria inside. Otherwise, the bacteria spread further. This is a critical step in progression of Legionnaire's disease, but the process behind it is poorly understood. My research will investigate the cellular pathways that allow macrophages to rupture the LCV and fight infection. I will grow macrophages derived from genetically diverse mice, expose them to Legionella, and identify genetic factors that control LCV rupture and cellular death. Using genetic analysis and advanced microscopy, I will characterize the mechanisms behind this process. By uncovering how immune cells recognize and eliminate Legionella, this project will guide the development of new therapies to treat or prevent Legionnaires' disease. Notably, restriction of other pathogens, such as Chlamydia trachomatis, occurs in a similar fashion, so this work is likely to provide insights on additional infectious diseases. Ultimately, these discoveries could improve patient outcomes, reduce the burden of pneumonia and related infections, and strengthen our ability to protect public health.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Callon, Lily S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~